EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Optimal Inotropic Support Strategy in Low Cardiac Output Syndrome

Travis J Miles, Kyle W Blackburn, Marc R Moon, Subhasis Chatterjee

Seminars in Thoracic and Cardiovascular Surgery · 2025

DOI: 10.1053/j.semtcvs.2025.04.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Thoracic and Cardiovascular Surgery, 2025. Verfasst von Travis J Miles und 3 weiteren Autor:innen. Beteiligte Einrichtung: Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas. Hauptthemen laut MEDLINE: Cardiotonic Agents, Cardiac Output, Low, Hemodynamics, Cardiac Surgical Procedures. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Heart, Lung, and Blood Institute, National Institutes of Health, Texas Heart Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Low cardiac output syndrome (LCOS), a form of cardiogenic shock that occurs after cardiac surgery, is associated with an elevated risk of morbidity and mortality. Generally, LCOS is managed medically with inotropes and vasopressors to optimize hemodynamics. However, randomized data comparing the efficacy of individual inotropes in treating LCOS are limited. Consequently, there is little consensus regarding the optimal inotrope strategy, and practice patterns vary widely. This review synthesizes current evidence on pharmacologic, non-mechanical circulatory support strategies for managing LCOS, advocating for a personalized approach tailored to the individual patient's hemodynamic profile and inotropic requirements. Currently available vasoactive agents are discussed, and guidance is provided on their use across specific clinical contexts to support individualized treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiotonic AgentsCardiac Output, LowHemodynamicsCardiac Surgical ProceduresMyocardial ContractionVasoconstrictor AgentsHumansTreatment OutcomeRisk FactorsRecovery of Function

Stichwörter der Autor:innen

inodilatorinotropeslow cardiac output syndromeshock

Substanzen

Cardiotonic AgentsVasoconstrictor Agents

Autor:innen und Institutionen

  • Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.
  • Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas; Department of Cardiovascular Surgery, The Texas Heart Institute, Houston, Texas.
  • Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas; Department of Cardiovascular Surgery, The Texas Heart Institute, Houston, Texas. Electronic address: Subhasis.Chatterjee@bcm.edu.

Förderung

  • National Heart, Lung, and Blood Institute
  • National Institutes of Health
  • Texas Heart Institute

Zitieren

APA

Miles, T. J., Blackburn, K. W., Moon, M. R., & Chatterjee, S. (2025). Optimal Inotropic Support Strategy in Low Cardiac Output Syndrome. Seminars in Thoracic and Cardiovascular Surgery. https://doi.org/10.1053/j.semtcvs.2025.04.002

Vancouver

Miles TJ, Blackburn KW, Moon MR, Chatterjee S. Optimal Inotropic Support Strategy in Low Cardiac Output Syndrome. Seminars in Thoracic and Cardiovascular Surgery. 2025. doi:10.1053/j.semtcvs.2025.04.002

BibTeX
@article{Miles2025,
  author = {Miles, Travis J and Blackburn, Kyle W and Moon, Marc R and Chatterjee, Subhasis},
  title = {Optimal Inotropic Support Strategy in Low Cardiac Output Syndrome},
  journal = {Seminars in Thoracic and Cardiovascular Surgery},
  year = {2025},
  doi = {10.1053/j.semtcvs.2025.04.002}
}
Kostenlos starten →